Tue, August 27, 2024
Mon, August 26, 2024
Fri, August 23, 2024
Thu, August 22, 2024

Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $209 on, Aug 23rd, 2024


//stocks-investing.news-articles.net/content/202 .. th-increased-target-to-209-on-aug-23rd-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $196 to $209 on, Aug 23rd, 2024.

Christopher has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Christopher


  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $218 on, Monday, August 12th, 2024
  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $200 on, Monday, August 5th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $205 on, Friday, July 26th, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Increased Target to $200 on, Friday, July 26th, 2024
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy with Increased Target to $210 on, Friday, July 26th, 2024
  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $214 on, Friday, July 19th, 2024
  • Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024

Publication Contributing Sources